Category Archives: Business and Investments

Latest From Business and Investments

Sens. Alexander and Burr Release “Innovation for Healthier Americans” Report


Today, Senate HELP Committee Chairman Lamar Alexander (R-Tenn.) and committee member Richard Burr (R-N.C.) released a report on the challenges of ‘getting safe treatments, devices and cures to patients more quickly and effectively.’ Specifically, the report looks at what is and is not working at the Food and Drug Administration and the National Institutes of Health. The report kicks off a major initiative by the Committee to examine challenges with drug and medical device development Read More >

Business and Investments, Health, Public Policy  |  Leave a comment  |  Email This Post

Op-Ed in Forbes on the Threat to Philanthropy


This week, Howard Husock extols the benefits of venture philanthropy through this Forbes op-ed. In the op-ed, Husock points out that private entities conduct a significant portion of applied research toward new drug development as referenced in this 2008 Manhattan Institute paper, “The Truth About Drug Innovation”, co-authored by two researchers from the Tufts University Center for the Study of Drug Development, and Institute Fellow Benjamin Zycher: “. . .among. . . thirty-five drugs and Read More >

Business and Investments, Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Announcing the BIO/Bloomberg Intelligence: 2015 Biotech Industry Outlook Survey


Click here for the BIO/Bloomberg Intelligence: 2015 Biotech Industry Outlook Survey. Your investment plans and budgets all include growth assumptions and market forecasts. Can you trust them? 2014 was another banner year for biotech IPOs, with 81 companies in our industry going public, an increase of nearly 90 percent over 2013. Now we turn our attention to the year ahead and what we can expect. More blue skies or dark clouds?  M&A surpassing last year Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,

Chairman Upton and Rep. DeGette Op-Ed: Can We Find Cures for 7,000 Diseases?

21st Century Cures Act

In a op-ed, Energy & Commerce Committee Chairman Fred Upton (R-MI) and Representative Diana DeGette (D-CO) provide highlights of policies that they intend to propose to help get more cures and treatments for the more than 7,000 diseases for which only 500 have cures and treatments. Chairman Upton and Rep. DeGette launched the 21st Century Cures Initiative to identify areas of reform to help ‘close the gap between the science of medicine and the Read More >

Business and Investments, Events, Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

J.P. Morgan Turns All Eyes toward Biotech

CEO2013_115x75_Thumbnail copy

BioWorld’s Peter Winter reports that the mood is upbeat at today’s kickoff of the 33rd annual J.P. Morgan Healthcare Conference in San Francisco (check out the story here, subscription required). Winter points to coming off ‘a record year in terms of raising capital, performance on the capital markets and partnering and mergers and acquisitions’ as one reason for the strong momentum at this year’s conference. Looking ahead, Roth Capital Partners’ John Chambers shared with Winter Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,